Position in IMUX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$627,865
+$450,607 QoQ
Shares Held
565,645
+70.4% QoQ
Ownership
4.15%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
24 quarters on record
Voting authority
Sole 69%
Shared 0%
None 31%
Common Shares in IMUX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026STATE STREET CORP holds $30,291,958,108 across 423 Biotechnology names. IMUX ranks #285 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
11,730,139 | $5,237,976,269 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
4,664,478 | $3,603,962,281 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
3,322,698 | $1,099,381,087 | |
| 4 | INSM |
INSMED Inc
|
5,551,699 | $907,813,820 | |
| 5 | INCY |
Incyte Corp
|
9,641,384 | $907,447,062 | |
| 6 | MRNA |
Moderna, Inc.
|
14,861,409 | $754,959,577 | |
| 7 | RPRX |
Royalty Pharma plc
|
10,989,851 | $527,183,152 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
16,186,613 | $448,369,180 |
All Filings in IMUX
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $627,865 | 565,645 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $177,258 | 331,945 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $292,775 | 331,945 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $231,697 | 331,945 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $331,300 | 303,945 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $303,945 | 303,945 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $275,789 | 167,145 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $172,608 | 155,503 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $172,263 | 130,503 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $188,704 | 125,803 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $184,930 | 125,803 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $315,765 | 125,803 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $187,446 | 125,803 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $108,084 | 77,203 | Shares | Defined | 2023-05-15 | |
| 2022-09-30 | $208,253 | 65,903 | Shares | Defined | 2022-11-15 | |
| 2022-06-30 | $228,683 | 65,903 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $3,611,197 | 319,575 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $4,440,480 | 464,000 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $3,902,354 | 440,944 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $4,306,888 | 351,296 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $3,969,362 | 249,019 | Shares | Defined | 2021-07-09 | |
| 2020-12-31 | $1,319,527 | 86,300 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $1,311,506 | 70,625 | Shares | Defined | 2020-11-10 | |
| 2020-06-30 | $404,323 | 33,360 | Shares | Defined | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||